AzTrials
AzTrials

Blow-Out FracturesNCT06369129

Accuracy& Orbital Volume Using Patient Specific Titanium Implant Vs Zirconia for Orbital Floor Reconstruction

A study testing Orbital floor reconstruction with Patient Specific Zirconia Implant and Orbital floor reconstruction with Patient Specific Titanium Implant in people with Blow-Out Fractures and Orbital Fractures, run by Cairo University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Comparative study used to assess if the patient specific zirconia implant will provide better accuracy, intraoperative adaptability, precise orbital volume and soft tissue reaction with more cost effectiveness than the patient specific titanium implants in orbital floor reconstruction after blow out fractures . Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
What is being tested?
Orbital floor reconstruction with Patient Specific Zirconia Implant and Orbital floor reconstruction with Patient Specific Titanium Implant
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteEgypt
Study dates
6 Apr 2024to Aug 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Patients with blow out fracture isolated and / or combined with other fracture.
  • Age group: from 18 to 60 years old
  • No sex predilection
  • Patients with no contraindications to surgical intervention.
  • Patients willing for the surgical procedure and follow-up, with an informed consent.

Who cannot join

  • Medically compromised patients.
  • Patients with history of previous orbital reconstruction surgery.
  • Uncooperative patients.
  • Patients with systemic contraindication to general anesthesia.

Trial locations and contacts

1 site in 1 country.

OLA A. ELMORSY, PHD contact

00201141234877

dr.ola.elmorsy@gmail.com

Egypt1 site, 1 recruiting
  • Cairo University

    Cairo, 11511

    OLA A. ELMORSY, PHD, 00201141234877, dr.ola.elmorsy@gmail.com

    Recruiting

Other trials in Egypt

About this study

Official title: Assessment of Accuracy and Orbital Volume Using Patient Specific Titanium Implant Vs Patient Specific Zirconia Implant for Orbital Floor Reconstruction in Blowout Fractures A Randomized Clinical Trial: Comparative Study

Comparative study used to assess if the patient specific zirconia implant will provide better accuracy, intraoperative adaptability, precise orbital volume and soft tissue reaction with more cost effectiveness than the patient specific titanium implants in orbital floor reconstruction after blow out fractures .

Read the detailed description

Patients of both groups will be subjected to:

  1. Case history including personal data, medical, surgical history and family history.
  2. A full examination of the cranial and maxillofacial skeleton and soft tissue .
  3. Evaluation of Visual Functions
  4. Ophthalmologic consultation and clearance
  5. Radiographic examination: CT scan
  6. All DICOM data will be imported to the surgical planning software.

Virtual planning:

  1. A midsagittal plane will be constructed then the normal orbit will be mirrored to the affected side.
  2. The mirrored orbital floor will be meshed with 1.6 mm holes then its peripheries will be extended downwards by 3 mm and meshed also in order to accommodate the fixation.
  3. The designed part will be subtracted then exported in Stereolithography (STL) format to be fabricated . The surgery will be done under General anesthesia and undertaken within 14 days to prevent fibrosis. Can be delayed 24-72 hours to allow the edema to subside before undertaking surgery. Intervention Group: -
  • The STL file will be milled from zirconium and then will be ready for sterilization and intraoperative fixation
  • A transconjunctival incision will be done to allow for good exposure that optimizes visualization of the orbital floor during the repair and insertion and fixation of the patient specific zirconia implant. Control Group: -
  • The STL file be milled from grade 4 titanium and then will be ready for sterilization and intraoperative fixation with the same surgical steps. Follow up: All patients will be examined clinically and radiographically, during postoperative 1st and 2nd week . Only one postoperative CT scan will be done after 2 weeks.
Being tested
Orbital floor reconstruction with Patient Specific Zirconia Implant, Orbital floor reconstruction with Patient Specific Titanium Implant
Medical subject headings
Orbital Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Orbital floor reconstruction with Patient Specific Zirconia ImplantProcedure or surgery

    Orbital floor reconstruction with Patient Specific Zirconia Implant will be done

  • Orbital floor reconstruction with Patient Specific Titanium ImplantProcedure or surgery

    Orbital floor reconstruction with Patient Specific Titanium Implant will be done

Study groups in NCT06369129
Study groupRoleWhat they receive
Orbital floor reconstruction with Patient Specific Zirconia ImplantExperimentalOrbital floor reconstruction with Patient Specific Zirconia Implant will be done
Receives: Procedure: Orbital floor reconstruction with Patient Specific Zirconia Implant
Orbital floor reconstruction with Patient Specific Titanium ImplantActive comparatorOrbital floor reconstruction with Patient Specific Titanium Implant will be done.
Receives: Procedure: Orbital floor reconstruction with Patient Specific Titanium Implant

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Orbital Volume

    will be measured with CT scan in mm3

    Measured: immediately post operative

Secondary outcomes (3)
  1. Accuracy of the patient specific implant in the orbital floor reconstruction

    will be measured with CT scan with superimposition of the preoperative CT scan and the mirrored image and the post operative CT scan . The difference will be measured by mm

    Measured: immediately post operative

  2. Cost effectiveness

    will compare between the prices of the patient specific implants the titanium and the zirconia and financial record will be kept with that in United states dollar . By the end of the study and comparison will be done to check which one was more cost effective

    Measured: through study completion, an average of 1 year

  3. Patient satisfaction

    will be assessed by a Questionnaire using Visual analogue scale , highest score will be more satisficed .The score is minimum 1 and maximum 10.

    Measured: through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Apr 2024
  2. Study start6 Apr 2024
  3. Primary completionAug 2025 (estimated)
  4. Study completionAug 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
A randomized clinical trial. * Parallel group study. * A trial will be carried out in hospital of Oral and Maxillofacial surgery department - Faculty of Oral and Dental Medicine - Cairo University . * Equal randomization : participants with equal probabilities for intervention. * Positive controlled : Both groups receiving treatment.
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06369129
Sponsor's protocol ID
CEBD-CU-2024-06-16
Status last verified
Apr 2024
First submitted
6 Apr 2024
Last updated
17 Apr 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Orbital floor reconstruction with Patient Specific Zirconia Implant and Orbital floor reconstruction with Patient Specific Titanium Implant in people with Blow-Out Fractures and Orbital Fractures, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact OLA A. ELMORSY, PHD (00201141234877, dr.ola.elmorsy@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Orbital Volume (time frame: immediately post operative). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Apr 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in